Cargando…
Dual antiplatelet therapy for secondary prevention of coronary artery disease
Dual antiplatelet therapy (DAPT) combining aspirin and a P2Y(12) receptor inhibitor has been consistently shown to reduce recurrent major adverse cardiovascular events (MACE) in patients with acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI) for stable coronary art...
Autores principales: | Degrauwe, Sophie, Pilgrim, Thomas, Aminian, Adel, Noble, Stephane, Meier, Pascal, Iglesias, Juan F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652612/ https://www.ncbi.nlm.nih.gov/pubmed/29081979 http://dx.doi.org/10.1136/openhrt-2017-000651 |
Ejemplares similares
-
Complexity assessment and technical aspect of coronary angiogram and percutaneous coronary intervention following transcatheter aortic valve implantation
por: Perrin, Nils, et al.
Publicado: (2022) -
Successful percutaneous mechanical thrombectomy of an Impella CP-related femoral artery thrombosis
por: Degrauwe, Sophie, et al.
Publicado: (2021) -
Intracoronary adenosine-induced torsades de pointes during fractional flow reserve measurement
por: Degrauwe, Sophie, et al.
Publicado: (2019) -
Covered Stents for the Percutaneous Management of Delayed Coronary Wall Rupture Following Subadventitial Rotational Atherectomy
por: Degrauwe, Sophie, et al.
Publicado: (2020) -
Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England: a population-based cohort study emulating a ‘target trial’
por: Pufulete, Maria, et al.
Publicado: (2022)